Skip to main content
. 2021 Jan 22;10(3):415. doi: 10.3390/jcm10030415

Table 2.

Diabetic oral agents.

Agent Patients %
Metformin 31 62
Sulfonylureas 19 38
Acarbose 3 6
Incretin-based therapy 6 12
Thiazolidinedione therapy 1 2